植入式心臟整流去顫器(ICD)市場:各市場區隔規模，佔有率，法律規章，償付，手術，2033年為止的預測

植入式心律轉復除顫器 (ICD) 是一種電子設備，可監測心律，並在檢測到心律不整（心跳不規則）時發出電脈衝以恢復心臟的自然節律。 ICD 包含三個主要部分：脈衝產生器、電極和引線。但也有不帶引線的類型。

心臟驟停或心臟驟停 (SCA) 是指心臟因節律異常（例如心室顫動或室性心動過速）而無法將血液泵送到身體重要器官的情況。通常，這些異常節律是短暫且無害的。某些危險因素，如高血壓、肥胖、高膽固醇和糖尿病，會增加 SCA 的可能性。心臟驟停的唯一治療方法是去顫以恢復心臟功能，可以使用體外去顫器來完成，但存活的機會很低。醫師可能會為 SCA 高風險患者（例如患有冠狀動脈疾病或心肌病變的患者）開立抗心律不整藥物或植入式心臟復律去顫器。最初的植入式心臟復律去顫器僅設計用於偵測心室顫動，而不會偵測到室性心搏過速。 ICD 用於記錄心臟活動並向心臟傳送電擊或脈衝以治療危險的室性心律不整。

本報告提供全球植入式心臟整流去顫器(ICD)市場相關資料詳細考察，提供市場上競爭情形，SWOT分析，到2033年為止的市場預測，地區，各國的趨勢等資訊。

目錄

已上市的植入式心臟整流去顫器(ICD)和不斷變化的競爭格局

• 主要的產業趨勢洞察
• 植入式心臟整流去顫器(ICD)的各市場區隔整體市場收益和2015年～2033年的市場展望
• 各市場區隔的手術總數，台數，平均銷售價格，市場價值相關詳細資料

世界，地區，各國洞察

• 植入式心臟整流去顫器(ICD)市場SWOT分析
• 植入式心臟整流去顫器(ICD)市場相關競爭動態的洞察和趨勢
• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規狀況

Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart's rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart's natural rhythm. ICDs contain three main components: a pulse generator, electrodes, and leads. However, the devices can also be leadless.

Cardiac Arrest or Sudden Cardiac Arrest (SCA) is a condition in which abnormal rhythms like Ventricular Fibrillation and Ventricular Tachycardia prevents the heart from pumping blood to the vital organs of the body. Often these abnormal rhythms are momentary and harmless. Certain risk factors such as high blood pressure, obesity, high blood cholesterol, diabetes etc., can increase the chances of SCA. The only treatment of cardiac arrest is to defibrillate the heart to restore heart function which can be done using an external defibrillator, however, the chances of surviving an out of hospital cardiac arrest are thin. For patients with high risk of SCA, such as those with coronary artery disease or cardiomyopathy, a physician may prescribe anti-arrhythmic medication or an Implantable Cardioverter Defibrillator. The original implantable cardioverter-defibrillator was designed to detect only ventricular fibrillation and not for ventricular tachycardia. ICDs are used to record the heart's activity and treat dangerous ventricular arrhythmias with an electrical shock or pulse to the heart.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Implantable Cardioverter Defibrillators (ICD) and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Implantable Cardioverter Defibrillators (ICD) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Implantable Cardioverter Defibrillators (ICD) market.
• Competitive dynamics insights and trends provided for Implantable Cardioverter Defibrillators (ICD) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Biotronik SE & Co KG, MicroPort Scientific Corp.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Implantable Cardioverter Defibrillators (ICD) marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Implantable Cardioverter Defibrillators (ICD) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Implantable Cardioverter Defibrillators (ICD) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Implantable Cardioverter Defibrillators (ICD) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.